The G2019S LRRK2 mutation in Brazilian patients with Parkinson's disease:: Phenotype in monozygotic twins

被引:18
|
作者
Munhoz, Renato P. [1 ]
Wakutani, Yosuke [2 ]
Marras, Connie [3 ]
Teive, Helio A. [1 ]
Raskin, Salmo [4 ]
Werneck, Lineu C. [1 ]
Moreno, Danielle [2 ]
Sato, Christine [2 ]
Lang, Anthony E. [3 ,5 ]
Rogaeva, Ekaterina [2 ,5 ]
机构
[1] Univ Fed Parana, Hosp Clin, Neurol Serv, Movement Disorders Unit, Curitiba, Parana, Brazil
[2] Univ Toronto, Ctr Res Neurodegenerat Dis, Toronto, ON, Canada
[3] Univ Toronto, Toronto Western Hosp, Movement Disorders Ctr, Toronto, ON, Canada
[4] Genet Lab, Curitiba, Parana, Brazil
[5] Univ Hlth Network, Dept Med, Div Neurol, Toronto, ON, Canada
关键词
mutation; Parkinson's disease; G2919S; LRRK; Brazil;
D O I
10.1002/mds.21832
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Mutations in the Leucine-Rich Repeat Kinase 2 gene (LRRK2) are mainly responsible for idiopathic Parkinson's disease (PD) with either a dominant pattern of transmission or a sporadic occurrence due to the reduced penetrance. A majority of LRRK2 kindreds demonstrate an extremely variable age-at-onset in affected members of the same family. The G2019S is the most common LRRK2 mutation, which accounts for 1-5% PD patients in North America, and up to 40% of patients from an isolated Arab population. We assessed the frequency of the G2019S mutation in 83 Brazilian PD patients originally preselected for having an early age-at-onset (< 50 years) and/or a positive family history. The mutation was detected in three probands (3.5%). Our clinical findings in these kindreds include the first description of the phenotype in identical twins discordant for handedness (a general phenomenon found in similar to 25% monozygotic twins). However, both twins developed right asymmetric PD. The clinical presentation of twins was strikingly similar including an identical PD onset at age 60. This observation may suggest that genetic factors predominantly determine age-at-onset. (C) 2007 Movement Disorder Society.
引用
收藏
页码:290 / 294
页数:5
相关论文
共 50 条
  • [21] Frequency of the LRRK2 G2019S mutation in late-onset sporadic patients with Parkinson's disease
    Chien, Hsin Fen
    Figueiredo, Tamires Rocha
    Hollaender, Marianna Almeida
    Tofoli, Fabiano
    Takada, Leonel Tadao
    Pereira, Lygia do Veiga
    Barbosa, Egberto Reis
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2014, 72 (05) : 356 - 359
  • [22] LRRK2 G2019S mutation: frequency and haplotype data in South African Parkinson's disease patients
    Bardien, Soraya
    Marsberg, Angelica
    Keyser, Rowena
    Lombard, Debbie
    Lesage, Suzanne
    Brice, Alexis
    Carr, Jonathan
    JOURNAL OF NEURAL TRANSMISSION, 2010, 117 (07) : 847 - 853
  • [23] The LRRK2 G2019S mutation in a series of Argentinean patients with Parkinson's disease: Clinical and demographic characteristics
    Mabel Gatto, Emilia
    Parisi, Virginia
    Paola Converso, Daniela
    Jose Poderoso, Juan
    Cecilia Carreras, Maria
    Felix Marti-Masso, Jose
    Paisan-Ruiz, Coro
    NEUROSCIENCE LETTERS, 2013, 537 : 1 - 5
  • [24] Nonmotor Symptoms in LRRK2 G2019S Associated Parkinson's Disease
    Gaig, Carles
    Vilas, Dolores
    Infante, Jon
    Sierra, Maria
    Garcia-Gorostiaga, Ines
    Buongiorno, Mariateresa
    Ezquerra, Mario
    Jose Marti, Maria
    Valldeoriola, Francesc
    Aguilar, Miquel
    Calopa, Matilde
    Hernandez-Vara, Jorge
    Tolosa, Eduardo
    PLOS ONE, 2014, 9 (10):
  • [25] LRRK2 G2019S Mutation Inhibits Degradation of α-Synuclein in an In Vitro Model of Parkinson’s Disease
    Dan Hu
    Jian-yi Niu
    Jing Xiong
    Shu-ke Nie
    Fei Zeng
    Zhao-hui Zhang
    Current Medical Science, 2018, 38 : 1012 - 1017
  • [26] LRRK2 G2019S Mutation Inhibits Degradation of -Synuclein in an In Vitro Model of Parkinson's Disease
    Hu, Dan
    Niu, Jian-yi
    Xiong, Jing
    Nie, Shu-ke
    Zeng, Fei
    Zhang, Zhao-hui
    CURRENT MEDICAL SCIENCE, 2018, 38 (06) : 1012 - 1017
  • [27] A Possible Modifying Effect of the G2019S Mutation in the LRRK2 Gene on GBA Parkinson's Disease
    Omer, Nurit
    Giladi, Nir
    Gurevich, Tanya
    Bar-Shira, Anat
    Gana-Weisz, Mali
    Goldstein, Orly
    Kestenbaum, Meir
    Cedarbaum, Jesse M.
    Orr-Urtreger, Avi
    Mirelman, Anat
    Thaler, Avner
    MOVEMENT DISORDERS, 2020, 35 (07) : 1249 - 1253
  • [28] Motor Phenotype of LRRK2 G2019S Carriers in Early-Onset Parkinson Disease
    Alcalay, Roy N.
    Mejia-Santana, Helen
    Tang, Ming Xin
    Rosado, Llency
    Verbitsky, Miguel
    Kisselev, Sergey
    Ross, Barbara M.
    Louis, Elan D.
    Comella, Cynthia L.
    Colcher, Amy
    Jennings, Danna
    Nance, Martha A.
    Bressman, Susan
    Scott, William K.
    Tanner, Caroline
    Mickel, Susan F.
    Andrews, Howard F.
    Waters, Cheryl H.
    Fahn, Stanley
    Cote, Lucien J.
    Frucht, Steven J.
    Ford, Blair
    Rezak, Michael
    Novak, Kevin
    Friedman, Joseph H.
    Pfeiffer, Ronald
    Marsh, Laura
    Hiner, Bradley
    Siderowf, Andrew
    Caccappolo, Elise
    Ottman, Ruth
    Clark, Lorraine N.
    Marder, Karen S.
    ARCHIVES OF NEUROLOGY, 2009, 66 (12) : 1517 - 1522
  • [29] The LRRK2 G2019S mutation status does not affect the outcome of subthalamic stimulation in patients with Parkinson's disease
    Greenbaum, Lior
    Israeli-Korn, Simon D.
    Cohen, Oren S.
    Elincx-Benizri, Sandra
    Yahalom, Gilad
    Kozlova, Evgenia
    Strauss, Hanna
    Molshatzki, Noa
    Inzelberg, Rivka
    Spiegelmann, Roberto
    Israel, Zvi
    Hassin-Baer, Sharon
    PARKINSONISM & RELATED DISORDERS, 2013, 19 (11) : 1053 - 1056
  • [30] G2019S Variation in LRRK2: An Idea Model for the Study of Parkinson's Disease?
    Ren, Chao
    Ding, Yu
    Wei, Shizhuang
    Guan, Lina
    Zhang, Caiyi
    Ji, Yongqiang
    Wang, Fen
    Yin, Shaohua
    Yin, Peiyuan
    FRONTIERS IN HUMAN NEUROSCIENCE, 2019, 13